Xia Mao

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Gene Expression

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

International journal of cancer

Diagnostics (Basel, Switzerland)

Case reports in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xiwen Tong, Mengyuan Li, Jie Jin, Yi Li, Li Li, Yizhou Peng, Lifang Huang, Bin Xu, Fankai Meng, Xia Mao, Liang Huang, Wei Huang, Donghua Zhang
Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. International journal of cancer 152 (10) (2023)
Yilei Yang, null Aruna, Bin Cheng, Dingkun Xiong, Dong Kuang, Haochen Cui, Si Xiong, Xia Mao, Yunlu Feng, Yuchong Zhao
Comparison of Fine-Needle Biopsy (FNB) versus Fine-Needle Aspiration (FNA) Combined with Flow Cytometry in the Diagnosis of Deep-Seated Lymphoma. Diagnostics (Basel, Switzerland) 13 (17) (2023)
Xiwen Tong, Mengyuan Li, Jie Jin, Yi Li, Li Li, Yizhou Peng, Lifang Huang, Bin Xu, Fankai Meng, Xia Mao, Liang Huang, Wei Huang, Donghua Zhang
Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. International journal of cancer (2023)
Xiwen Tong, Mengyuan Li, Jie Jin, Yi Li, Li Li, Yizhou Peng, Lifang Huang, Bin Xu, Fankai Meng, Xia Mao, Liang Huang, Wei Huang, Donghua Zhang
Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. International journal of cancer (2023)
Xiwen Tong, Mengyuan Li, Jie Jin, Yi Li, Li Li, Yizhou Peng, Lifang Huang, Bin Xu, Fankai Meng, Xia Mao, Liang Huang, Wei Huang, Donghua Zhang
Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. International journal of cancer 152 (10) (2023)
Xiwen Tong, Mengyuan Li, Jie Jin, Yi Li, Li Li, Yizhou Peng, Lifang Huang, Bin Xu, Fankai Meng, Xia Mao, Liang Huang, Wei Huang, Donghua Zhang
Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. International journal of cancer 152 (10) (2023)
Xiwen Tong, Mengyuan Li, Jie Jin, Yi Li, Li Li, Yizhou Peng, Lifang Huang, Bin Xu, Fankai Meng, Xia Mao, Liang Huang, Wei Huang, Donghua Zhang
Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. International journal of cancer 152 (10) (2023)
Hong-Yan Ji, Xiaolu Long, Jia Gu, Jin Jin, Xia Mao, Zhiqiong Wang, Heng Ma, Liting Chen
Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series. Diagnostics (Basel, Switzerland) 11 (11) (2021)
Chunyan Wang, Xia Mao, Songya Liu, Cheng He, Ying Wang, Li Zhu, Yangyang Wang, Yicheng Zhang
The Early Diagnostic Dilemma in Angioimmunoblastic T Cell Lymphoma with Excessive Plasma Cells Proliferation. Case reports in medicine 2021 (2021)